Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 2/3 1

Status

Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 11Head & Neck 5Gastrointestinal 5CNS 5Thoracic 4Other hematologic neoplasm 4Lymphoid 4Dermatologic 2Breast 2Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1NET 1Gynecologic 1Endocrine 1

Conditions

Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Papillary Thyroid Microcarcinoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 85pembrolizumab 76Magnetic Resonance Spectroscopy 46Radiotherapy, Intensity-Modulated 41Specimen Handling 36Cetuximab 36Carboplatin 35Radiotherapy 34Nivolumab 28Paclitaxel 24Radiation 22Platinum 22Docetaxel 20Biopsy 201,2-diaminocyclohexaneplatinum II citrate 20Gemcitabine 19Surveys and Questionnaires 15Fluorouracil 14toripalimab 13Standard of Care 12Taxes 11cemiplimab 9atezolizumab 9Ipilimumab 9Drug Therapy 9Cyclophosphamide 9X-Rays 8Surgical Procedures, Operative 8Radiosurgery 7Immunoglobulin G 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Watchful Waiting × Head & Neck × 90 days × Clear all
NCT03811015 2026-05-29

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
636 enrolled
Head & Neck

Oropharyngeal Neoplasms

NCT06998342 2026-05-26

MOHSAHRTSS

University of Vermont Medical Center

Phase 2 Recruiting
24 enrolled
Head & Neck

Head and Neck Neoplasms

NCT07513389 2026-05-20

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

Medical University of South Carolina

Phase 2 Recruiting
36 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT02135042 2026-05-07

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

NRG Oncology

Phase 2/3 Active not recruiting
685 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT02609685 2026-05-07

PMCAS

Cedars-Sinai Medical Center

Phase NA Recruiting
216 enrolled
Head & Neck

Papillary Thyroid Microcarcinoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡